Chen P - Search Results

1

Circulating CD45RA^-Foxp3⁺⁺ Treg cells serve as a biomarker for predicting minimal clinical manifestations status of myasthenia gravis.

Lu Y, Ma Q, Yu L, Liu X, Chen P, Liu W. Lu Y, et al. Among authors: chen p. Life Sci. 2024 Dec 1;358:123162. doi: 10.1016/j.lfs.2024.123162. Epub 2024 Oct 19. Life Sci. 2024. PMID: 39433086

2

Clinical outcome and predictive factors of irradiation-associated myasthenia gravis exacerbation in thymomatous patients.

Li Y, Chen P, Ding L, Luo C, Wang H, Chen Z, Su C, Feng H, Huang X, Xia W, Liu W. Li Y, et al. Among authors: chen z, chen p. Neurol Sci. 2015 Nov;36(11):2121-7. doi: 10.1007/s10072-015-2325-8. Epub 2015 Jul 26. Neurol Sci. 2015. PMID: 26209927

3

Leflunomide treatment in corticosteroid-dependent myasthenia gravis: an open-label pilot study.

Chen P, Feng H, Deng J, Luo Y, Qiu L, Ou C, Liu W. Chen P, et al. J Neurol. 2016 Jan;263(1):83-8. doi: 10.1007/s00415-015-7944-8. Epub 2015 Oct 29. J Neurol. 2016. PMID: 26514837

4

Thymectomy is a beneficial therapy for patients with non-thymomatous ocular myasthenia gravis: a systematic review and meta-analysis.

Zhu K, Li J, Huang X, Xu W, Liu W, Chen J, Chen P, Feng H. Zhu K, et al. Among authors: chen j, chen p. Neurol Sci. 2017 Oct;38(10):1753-1760. doi: 10.1007/s10072-017-3058-7. Epub 2017 Jul 13. Neurol Sci. 2017. PMID: 28707128 Review.

5

Clinical outcome and predictive factors of postoperative myasthenic crisis in 173 thymomatous myasthenia gravis patients.

Li Y, Wang H, Chen P, Chen Z, Su C, Luo C, Feng H, Liu W. Li Y, et al. Among authors: chen z, chen p. Int J Neurosci. 2018 Feb;128(2):103-109. doi: 10.1080/00207454.2017.1366905. Epub 2017 Oct 2. Int J Neurosci. 2018. PMID: 28803488

6

Clinical Characteristics of Juvenile Myasthenia Gravis in Southern China.

Huang X, Li Y, Feng H, Chen P, Liu W. Huang X, et al. Among authors: chen p. Front Neurol. 2018 Feb 27;9:77. doi: 10.3389/fneur.2018.00077. eCollection 2018. Front Neurol. 2018. PMID: 29535672 Free PMC article.

7

Imbalance of the two main circulating dendritic cell subsets in patients with myasthenia gravis.

Chen P, Li Y, Huang H, Li Y, Huang X, Chen Z, Liu X, Qiu L, Ou C, Huang Z, Lin Z, Ran H, Liu W. Chen P, et al. Among authors: chen z. Clin Immunol. 2019 Aug;205:130-137. doi: 10.1016/j.clim.2018.10.012. Epub 2018 Oct 22. Clin Immunol. 2019. PMID: 30359772

8

AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature review.

Lu Y, Ran H, Yang W, Ma Q, Qiu L, Ou C, Chen P, Lin Z, Liu W. Lu Y, et al. Among authors: chen p. Neuromuscul Disord. 2020 Jul;30(7):534-538. doi: 10.1016/j.nmd.2020.03.012. Epub 2020 Apr 13. Neuromuscul Disord. 2020. PMID: 32387283 Review.

9

Quantitative features and clinical significance of two subpopulations of AChR-specific CD4+ T cells in patients with myasthenia gravis.

Liu X, Ma Q, Qiu L, Ou C, Lin Z, Lu Y, Huang H, Chen P, Huang Z, Liu W. Liu X, et al. Among authors: chen p. Clin Immunol. 2020 Jul;216:108462. doi: 10.1016/j.clim.2020.108462. Epub 2020 May 11. Clin Immunol. 2020. PMID: 32437925

10

Circulating Th1/17 cells serve as a biomarker of disease severity and a target for early intervention in AChR-MG patients.

Ma Q, Ran H, Li Y, Lu Y, Liu X, Huang H, Yang W, Yu L, Chen P, Huang X, Qiu L, Lin Z, Ou C, Liu W. Ma Q, et al. Among authors: chen p. Clin Immunol. 2020 Sep;218:108492. doi: 10.1016/j.clim.2020.108492. Epub 2020 Jun 8. Clin Immunol. 2020. PMID: 32526271

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,387 results

Search Page

Filters